FREDUNBSEFREDUN PHARMACEUTICALS LHighNeutral
Announced Fri, 23 Oct, 2026 · 18:26 IST

14,667 warrants convert into 44,000 equity shares

Warrants ConvertedFund Raising View source PDFExplain this filing

FREDUN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.3%Reaction day
₹1374.00
prior close
₹1368.40
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.7% vs market
Pharmaceuticals peers, median of 174sector+1.2%-1.5% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-1.2
15m
-0.2
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.3+0.4-0.7+1.2-1.5
Next day
+6.0+2.1+3.8+3.1+2.9
2d
+7.2pendingpending+4.7+2.5
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board allotted 44,000 fully paid equity shares of Rs 10 each to three non-promoter investors after they converted 14,667 warrants and paid the balance amount. Following a 1:2 bonus issue, each warrant was adjusted to three shares. The new shares rank equally with existing shares.

Likely market impact

The issue creates minor dilution for existing shareholders, while the company has received the full warrant consideration.